FEATURED/ARCHIVES (01/05/24)
Medication Use, Service Utilization, and Medical Costs Associated with New Episodes of Bipolar Disorder: Evidence from a Retrospective Claims Database · July 2007
Articles
NCBI>Primary Care Companion for CNS Disorders
Pharmaco-Utilisation and Related Costs of Drugs Used to Treat Schizophrenia and Bipolar Disorder in Italy: The IBIS Study · October 2014
Articles
BMC Psychiatry
A Rapid and Systematic Review and Economic Evaluation of the Clinical Effectiveness and Cost-Effectiveness of Newer Drugs for Treatment of Mania Associated with Bipolar Affective Disorder · May 2004
Publications (Books-Reports)
National Institute for Health Research
Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review · July 2019
Articles (Manuscripts-Versions)
PubMed Central>International Journal of Technology Assessment in Health Care
Lurasidone Hydrochloride for Bipolar Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
The Cost-Effectiveness of Lamotrigine in the Maintenance Treatment of Adults with Bipolar I Disorder · May 2006
Articles
Journal of Managed Care and Specialty Pharmacy
Healthcare Resource Utilization, Costs and Treatment Patterns in Patients with Bipolar Disorder Treated with Lurasidone or Cariprazine · February 2021
Articles
Journal of Medical Economics
Cost-Effectiveness of Asenapine in the Treatment of Patients with Bipolar I Disorder with Mixed Episodes in an Italian Context · July 2014
Articles
Advances in Therapy
Adherence, Persistence of Use, and Costs Associated with Second-Generation Antipsychotics for Bipolar Disorder · September 2011
Articles
Psychiatric Services
Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder in Canada · January 2014
Articles
BMC Psychiatry
Divalproex Sodium versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes (NHS Economic Evaluation Database) · March 2003
Abstracts
University of York>Journal of Clinical Psychiatry
Cost Effectiveness of Olanzapine in Prevention of Affective Episodes in Bipolar Disorder in the United Kingdom · October 2006
Abstracts
Journal of Psychopharmacology
One-Year Risk of Psychiatric Hospitalization and Associated Treatment Costs in Bipolar Disorder Treated with Atypical Antipsychotics: A Retrospective Claims Database Analysis · January 2011
Articles
BMC Psychiatry
Cost-Effectiveness of Structured Group Psychoeducation versus Unstructured Group Support for Bipolar Disorder: Results from a Multi-Centre Pragmatic Randomised Controlled Trial · January 2017
Abstracts
Journal of Affective Disorders
Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder · February 2013
Articles (Manuscripts-Versions)
PubMed Central>American Journal of Managed Care
Hospital Treatment, Mortality and Healthcare Costs in Relation to Socioeconomic Status among People with Bipolar Affective Disorder · January 2016
Articles
BJPsych Open
Internet-Delivered Psychological Treatments for Mood and Anxiety Disorders: A Systematic Review of Their Efficacy, Safety, and Cost-Effectiveness · May 2014
Articles
PLOS ONE